Fermion specializes in AI-enabled drug discovery and modalities for identifying small molecule drugs to progress towards Phases 1 and 2 clinical trials
Here at Fermion, we integrate several cutting-edge technologies across AI, Biology, medicinal chemistry and medicine to develop innovative drug therapies. Our use of advanced techniques such as deep learning, reinforcement learning, generative adversarial networks, big data, and knowledge graphs helps us enhance drug development. This strategy will ultimately lead to refined preclinical research and offer superior treatment options for a variety of diseases. Read More
AI technology is breaking new ground in drug development,
AI Drug Discovery Solution
By incorporating AI technology into the traditional drug discovery pathway and leveraging Fermion’s Drug Studio AI platform, we can efficiently generate molecules with optimal comprehensive parameters. By utilizing this approach, Fermion can specialize in rapid design, large-scale screening, and precise calculations to effectively improves the success rate of drug discovery.